Eupraxia Pharmaceuticals (EPRX) Current Leases (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) posted Current Leases of $159,877 for Q2 2026, up 355.9% from $35,065 a year earlier but down 21.4% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Current Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, Eupraxia Pharmaceuticals' Current Leases came in at $78,452, up 9.2% from FY2024.
- Annual Current Leases has increased for three consecutive years, with a three-year compound annual growth rate of 15.9% (FY2022 to FY2025).
- In prior years, Eupraxia Pharmaceuticals' Current Leases was $71,859 in FY2024 (+34.8%), $53,316 in FY2023 (+5.8%) and $50,403 in FY2022.
- Quarterly Current Leases has run from a low of $35,065 in Q2 2025 to a high of $203,510 in Q1 2026 over five years.
- On a year-over-year basis, Current Leases has increased in each of the last three quarters, with growth averaging 171.4% over the last four quarters.
- According to Business Quant data, Current Leases for the three prior quarters was $203,510 (Q1 2026), $78,452 (Q4 2025) and $76,136 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | 511,977.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 511,977.00 |
| Jun 30, 2026 | 159,877.00 |
| Mar 31, 2026 | 203,510.00 |
| Dec 31, 2025 | 78,452.00 |
| Sep 30, 2025 | 76,136.00 |
| Jun 30, 2025 | 35,065.00 |
| Mar 31, 2025 | 52,774.00 |
| Dec 31, 2024 | 71,859.00 |
| Dec 31, 2023 | 53,316.00 |
| Dec 31, 2022 | 50,403.00 |
API Access
Eupraxia Pharmaceuticals Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();